{"id":2039,"date":"2017-03-21T16:53:37","date_gmt":"2017-03-21T20:53:37","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=2039"},"modified":"2017-03-21T17:05:20","modified_gmt":"2017-03-21T21:05:20","slug":"secondaries-announced-3-21-2017","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-3-21-2017\/","title":{"rendered":"Secondaries Announced 3.21.2017"},"content":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis.<\/strong><\/h4>\n

If having\u00a0real-time alerts for secondary offerings<\/strong><\/a>\u00a0would be an advantage to you,\u00a0inquire about a subscription today!<\/a><\/p>\n

\n

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period. Spot secondaries or block trades due to the very short duration of announcement to trading, may take longer to \u201cwork\u201d, and should be judged accordingly. (the key is the pricing for spots and or blocks\u2026even more so than scheduled secondaries)
\nCompany: Regenxbio Inc.<\/strong>
\nSymbol: RGNX
\nPrice: Last Trade $22.10
\nTrade Date: Subscription Needed<\/a>
\nShares: 3.4 million
\nRe-Offer Range: Subscription Needed<\/a>
\nUnderwriter(s) Morgan Stanley BofA Merrill Lynch, Piper Jaffray
\nCo-Manager: Chardan Capital Markets
\nRating = Subscription Needed<\/a><\/p>\n

Company: Vital Therapies, Inc.<\/strong>
\nSymbol: VTL
\nPrice: Last Trade $4.25
\nRe-offer: Subscription Needed<\/a>
\nTrade Date: Subscription Needed<\/a>
\nShares: 7.3 million
\nUnderwriter(s) Raymond James
\nCo-Manager: National Securities
\nRating = Subscription Needed<\/a><\/p>\n

Company: Easterly Government Properties, Inc.<\/strong>
\nSymbol: DEA
\nPrice: Last Trade $19.67
\nTrade Date: Subscription Needed<\/a>
\nShares: 4.3 million
\nRe-Offer Range: Subscription Needed<\/a>
\nUnderwriter(s) Jefferies, Citigroup, Raymond James, RBC Capital Markets
\nRating = Subscription Needed<\/a><\/p>\n

Company: Adaptimmune Therapeutics plc<\/strong>
\nSymbol: ADAP
\nPrice: Last Trade $4.29
\nRe-offer: Subscription Needed<\/a>
\nTrade Date: Subscription Needed<\/a>
\nShares: Subscription Needed<\/a>
\nUnderwriter(s) Citigroup, Cowen and Company, Leerink Partners
\nRating = Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis. If having\u00a0real-time alerts for secondary offerings\u00a0would be an advantage to you,\u00a0inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[344,63,624,664],"class_list":["post-2039","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-adap","tag-dea","tag-rgnx","tag-vtl"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2039","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=2039"}],"version-history":[{"count":3,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2039\/revisions"}],"predecessor-version":[{"id":2042,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2039\/revisions\/2042"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=2039"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=2039"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=2039"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}